Company name: Demecan
Description: Producer and supplier of cannabis intended to be used for medicinal drug research and development process. The company specializes in the cultivation and processing of medical cannabis plants that are grown using sterilized water from a pharmaceutical reverse osmosis system indoors under complete climate control, thereby providing the healthcare industry with clean and natural cannabis without pesticides and irradiation.
Year founded: 2017
Industry: Consumer Products and Services (B2C) | Group: | Code:
Start up capital raised (USD Million): 7.71
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company raised an undisclosed amount of venture funding from PHK Enterprise and other investors on May 19, 2020. The funds will be used by the company to expand the production facility and strengthen its operations.
Number of active investors:
Profile last updated: 20-May-2020
Last known valuation:
Last known valuation date: